Kolla Bhanu Prakash, Schneekloth Terry, Mansukhani Meghna P, Biernacka Joanna M, Hall-Flavin Daniel, Karpyak Victor, Geske Jennifer, Frye Mark A
Department of Psychiatry and Sleep Medicine, Affiliated Community Medical Centers, Willmar, Minnesota.
Am J Addict. 2015 Jun;24(4):362-7. doi: 10.1111/ajad.12199. Epub 2015 Mar 24.
Sleep disturbances are extremely common in alcohol recovery. Systematic research into the relationship between alcohol relapse and sleep disturbances using validated scales and accounting for potential confounders is lacking.
Patients admitted to a 1-month residential addiction treatment program were administered the Pittsburg Sleep Quality Index (PSQI) at admission/discharge. In addition, the Alcohol Use Disorders Identification Test (AUDIT), Patient Health Questionnaire-9 (PHQ-9), and Pennsylvania Alcohol Craving Scale (PACS) were administered. Patients were contacted every 3 months over 1 year following discharge. Associations of clinical factors with time until relapse were examined using univariate Cox proportional hazard models.
One-hundred and nineteen patients with alcohol use disorders met inclusion criteria (mean age 50.6 ± 13.2 years, 57% male), relapse data were available for 81 patients. Eighty percent of subjects had other psychiatric diagnoses, 66.3% had sleep disturbances at the time of admission, and 57.1% were using hypnotics; 49.1% of patients had sleep disturbances at discharge. Sleep disturbances at admission and discharge were not associated with alcohol relapse at 12 months (OR = 1.00, 95% CI = 0.89-1.13; p = 0.95 and OR = 0.97, 95% CI = 0.86-1.09; p = 0.61). The PSQI sub-scale scores were also not associated with relapse at 12 months. The use of alcohol to help fall asleep (OR = 3.26, 95% CI = 1.33-7.95; p = 0.008), hypnotic use at admission (OR = 4.03, 95% CI = 1.63-9.97; p = 0.002) and age (OR = 1.03, 95% CI = 1.00-1.06; p = 0.035) were associated with relapse over 12 months.
In patients completing a residential treatment program, sleep disturbances as measured by the PSQI were not associated with alcohol relapse at 12 months. Alcohol use as a hypnotic and hypnotic use at admission were associated with subsequent relapse.
睡眠障碍在酒精戒断康复过程中极为常见。目前缺乏使用经过验证的量表并考虑潜在混杂因素对酒精复吸与睡眠障碍之间关系进行的系统研究。
入住为期1个月的住院成瘾治疗项目的患者在入院/出院时接受匹兹堡睡眠质量指数(PSQI)评估。此外,还进行了酒精使用障碍识别测试(AUDIT)、患者健康问卷-9(PHQ-9)和宾夕法尼亚酒精渴望量表(PACS)评估。出院后1年内每3个月对患者进行一次随访。使用单变量Cox比例风险模型检查临床因素与复吸时间的关联。
119名酒精使用障碍患者符合纳入标准(平均年龄50.6±13.2岁,57%为男性),81名患者有复吸数据。80%的受试者有其他精神科诊断,66.3%的患者入院时存在睡眠障碍,57.1%的患者正在使用催眠药;49.1%的患者出院时存在睡眠障碍。入院和出院时的睡眠障碍与12个月时的酒精复吸无关(OR = 1.00,95%CI = 0.89 - 1.13;p = 0.95和OR = 0.97,95%CI = 0.86 - 1.09;p = 0.61)。PSQI子量表得分在12个月时也与复吸无关。使用酒精助眠(OR = 3.26,95%CI = 1.33 - 7.95;p = 0.008)、入院时使用催眠药(OR = 4.03,95%CI = 1.63 - 9.97;p = 0.002)和年龄(OR = 1.03,95%CI = 1.00 - 1.06;p = 0.035)与12个月内的复吸有关。
在完成住院治疗项目的患者中,PSQI测量的睡眠障碍与12个月时的酒精复吸无关。将酒精用作催眠药以及入院时使用催眠药与随后的复吸有关。